Viewing Study NCT00561951


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-02 @ 11:16 AM
Study NCT ID: NCT00561951
Status: COMPLETED
Last Update Posted: 2011-07-14
First Post: 2007-11-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-11
Start Date Type: None
Primary Completion Date: 2009-01
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2007-11-19
First Submit QC Date: None
Study First Post Date: 2007-11-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-01-11
Results First Submit QC Date: None
Results First Post Date: 2010-09-09
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-07-11
Last Update Post Date: 2011-07-14
Last Update Post Date Type: ESTIMATED